Use of Amygdalin Analogues for the Treatment of Psoriasis
    1.
    发明申请
    Use of Amygdalin Analogues for the Treatment of Psoriasis 有权
    使用杏仁苷类似物治疗牛皮癣

    公开(公告)号:US20110028410A9

    公开(公告)日:2011-02-03

    申请号:US11754917

    申请日:2007-05-29

    CPC分类号: A61K31/7028

    摘要: The compounds of formula (1), wherein n is an integer from 0 to 4; R1 is a radical selected from the group consisting of H, CH3, CH2-CH3, C(CH3)3, COOH, CONH2 and C=CH; R2, R3, R4 and R5 are radicals independently selected from the group consisting of H, F, Cl, Br, (C1-C3)-alkoxyl and (C1-C4)-alkyl; and R6 is a radical selected from the group consisting of H, F, Cl, Br, (C1-C3)-alkoxyl, (C1-C4)-alkyl, R7, CH=CH-R7 and O-CH2-R7; wherein R7 is phenyl or phenyl mono- or independently di-substituted with F, Cl, Br, (C1-C3)-alkoxyl or (C1-C4)-alkyl, exhibit a similar chemotactic index to that of amygdalin (natural product whose chemotaxis profile is similar to that of peptide T) and, consequently, are useful for treating inflammatory and/or allergic dermatophathies, such as psoriasis, and are especially much less toxic than amygdalin.

    摘要翻译: 式(1)的化合物,其中n为0至4的整数; R1是选自H,CH3,CH2-CH3,C(CH3)3,COOH,CONH2和C = CH的基团; R2,R3,R4和R5是独立地选自H,F,Cl,Br,(C1-C3) - 烷氧基和(C1-C4) - 烷基的基团。 并且R 6是选自H,F,Cl,Br,(C 1 -C 3) - 烷氧基,(C 1 -C 4) - 烷基,R 7,CH = CH-R 7和O-CH 2 -R 7的基团; 其中R 7是苯基或被F,Cl,Br,(C 1 -C 3) - 烷氧基或(C 1 -C 4) - 烷基单取代或独立地取代的苯基,表现出与杏仁体相似的趋化指数(趋化性 特征与肽T相似),因此可用于治疗炎症和/或过敏性皮肤病,如牛皮癣,并且特别是比杏仁苷毒性低得多。

    Use of Amygdalin Analogues for the Treatment of Psoriasis
    2.
    发明申请
    Use of Amygdalin Analogues for the Treatment of Psoriasis 有权
    使用杏仁苷类似物治疗牛皮癣

    公开(公告)号:US20080125378A1

    公开(公告)日:2008-05-29

    申请号:US11754917

    申请日:2007-05-29

    CPC分类号: A61K31/7028

    摘要: The compounds of formula (1), wherein n is an integer from 0 to 4; R1 is a radical selected from the group consisting of H, CH3, CH2-CH3, C(CH3)3, COOH, CONH2 and C=CH; R2, R3, R4 and R5 are radicals independently selected from the group consisting of H, F, Cl, Br, (C1-C3)-alkoxyl and (C1-C4)-alkyl; and R6 is a radical selected from the group consisting of H, F, Cl, Br, (C1-C3)-alkoxyl, (C1-C4)-alkyl, R7, CH=CH-R7 and O-CH2-R7; wherein R7 is phenyl or phenyl mono- or independently di-substituted with F, Cl, Br, (C1-C3)-alkoxyl or (C1-C4)-alkyl, exhibit a similar chemotactic index to that of amygdalin (natural product whose chemotaxis profile is similar to that of peptide T) and, consequently, are useful for treating inflammatory and/or allergic dermatophathies, such as psoriasis, and are especially much less toxic than amygdalin.

    摘要翻译: 式(1)的化合物,其中n为0至4的整数; R 1是选自H,CH 3,CH 2 -CH 3,C(CH 3) 3 CO 3,COOH,CONH 2和C = CH; R 2,R 3,R 4和R 5是独立地选自H,F,Cl,Br,(C 1 -C 3 - ) - 烷氧基和(C - 烷基; - C 1 -C 4烷基; 并且R 6是选自H,F,Cl,Br,(C 1 -C 3 - ) - 烷氧基,(C 1 -C 3 - C 1 -C 4烷基,R 7,CH = CH-R 7和O-CH 2 -R 7; 其中R 7是苯基或被F,Cl,Br,(C 1 -C 3 -C 3) - 烷氧基单独或独立地二取代的苯基或(C 1) 表现出与杏仁体相似的趋化指数(趋化性状与肽T相似的天然产物),因此可用于治疗炎症 和/或过敏性皮肤病,例如牛皮癣,并且特别是比杏仁渣毒性低得多。